PAIGE - Trademark Details
Status: 700 - Registered
Serial Number
88308511
Registration Number
6206397
Word Mark
PAIGE
Status
700 - Registered
Status Date
2020-11-24
Filing Date
2019-02-20
Registration Number
6206397
Registration Date
2020-11-24
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2019-07-02
Attorney Name
Law Office Assigned Location Code
M70
Employee Name
MORRIS, KRISTINA KLOIB
Statements
Goods and Services
Downloadable software, namely, computer programs for artificial intelligence, machine learning, deep learning, statistical learning, data mining, and contextual prediction; downloadable software for use in disease pathology, namely, software that reads digital slides and provides diagnoses; downloadable software for use in evaluation of prognosis relating to diseases, states, or conditions; downloadable software for use in monitoring of diseases, states, or conditions; downloadable software for use to detect or identify predispositions to diseases, states, or conditions; downloadable software for use to detect or determine the recurrence of diseases, states, or conditions; downloadable software for use to detect, monitor, or evaluate patients' responses to treatment of diseases, states, or conditions; downloadable software for use in clinical management of diseases, states, or conditions; downloadable software for use in the selection of treatment for diseases, states, or conditions; downloadable software for use in prevention of diseases, states, or conditions, namely, software that reviews and analyzes clinical pathology slides, and identifies measures to prevent future disease development; downloadable software for use in palliation or treatment of diseases, states or conditions; downloadable software for use in research or development in the field of life sciences; downloadable software for use in research or development in the field of medicine; downloadable software for use in research or development in the field of healthcare; downloadable software for use in research or development in the field of cancer; downloadable software for use in research or development in the field of oncology; downloadable software for use in research or development in the field of pathology; recorded software, namely, computer programs for artificial intelligence, machine learning, deep learning, statistical learning, data mining, and contextual prediction; recorded software for use in disease pathology, namely, software that reads digital slides and provides diagnoses; recorded software for use in evaluation of prognosis relating to diseases, states, or conditions; recorded software for use in monitoring of diseases, states, or conditions; recorded software for use to detect or identify predispositions to diseases, states, or conditions; recorded software for use to detect or determine the recurrence of diseases, states, or conditions; recorded software for use to detect, monitor, or evaluate patients' responses to treatment of diseases, states, or conditions; recorded software for use in clinical management of diseases, states, or conditions; recorded software for use in the selection of treatment for diseases, states, or conditions; recorded software for use in prevention of diseases, states, or conditions, namely, software that reviews and analyzes clinical pathology slides, and identifies measures to prevent future disease development; recorded software for use in palliation or treatment of diseases, states or conditions; recorded software for use in research or development in the field of life sciences; recorded software for use in research or development in the field of medicine; recorded software for use in research or development in the field of healthcare; recorded software for use in research or development in the field of cancer; recorded software for use in research or development in the field of oncology; recorded software for use in research or development in the field of pathology
Goods and Services
Software as a service (SaaS) services featuring software for artificial intelligence, machine learning, deep learning, statistical learning, data mining, and contextual prediction; software as a service (SaaS) services featuring software for use in disease pathology, namely, software that reads digital slides and provides diagnoses; software as a service (SaaS) services featuring software for use in diagnosis of diseases, states, or conditions; software as a service (SaaS) services featuring software for use in evaluation of prognosis relating to diseases, states, or conditions; software as a service (SaaS) services featuring software for use in monitoring of diseases, states, or conditions; software as a service (SaaS) services featuring software for use to detect or identify predispositions to diseases, states, or conditions; software as a service (SaaS) services featuring software to detect the recurrence of diseases, states, or conditions; software as a service (SaaS) services featuring software to detect, monitor, or evaluate patients' responses to treatment of diseases, states, or conditions; software as a service (SaaS) services featuring software for use in clinical management of diseases, states, or conditions; software as a service (SaaS) services featuring software for use in the selection of treatment of diseases, states, or conditions; software as a service (SaaS) services featuring software for use in prevention of diseases, states, or conditions; software as a service (SaaS) services featuring software for use in palliation or treatment of diseases, states, or conditions; software as a service (SaaS) services featuring software for use in research or development in the field of life sciences; software as a service (SaaS) services featuring software for use in research or development in the field of medicine; software as a service (SaaS) services featuring software for use in research or development in the field of healthcare; software as a service (SaaS) services featuring software for use in research or development in the field of cancer; software as a service (SaaS) services featuring software for use in research or development in the field of oncology; software as a service (SaaS) services featuring software for use in research or development in the field of pathology; design and development of AI-powered computer software that analyzes clinical pathology slides and diagnoses diseases; medical research; scientific research and development services in the field of pathology; research and development services in the field of medicine; research and development services in the field of cancer; research and development services in the field of healthcare; research and development services in the field of life sciences; research and development services in the field of oncology; medical and scientific research services in the field of pathology; medical and scientific research services in the field of cancer; medical and scientific research services in the field of healthcare; medical and scientific research services in the field of life sciences; medical and scientific research services in the field of oncology; research and development of technology in the field of pathology; research and development of technology in the field of medicine; research and development of technology in the field of cancer; research and development of technology in the field of healthcare; research and development of technology in the field of life sciences; research and development of technology in the field of oncology; providing medical research and scientific research information via the internet; electronic scanning of clinical pathology slides; software as a service services (SaaS) featuring software for use in the analysis of clinical pathology slides; medical and scientific testing services for research purposes
Goods and Services
Medical services; cancer therapy services; medical testing, namely, the review and analysis of patients' clinical slides to identify additional recommended medical testing; medical testing for the diagnosis of diseases, states, or conditions; medical testing for evaluation of prognosis relating to diseases, states, or conditions; medical testing for the monitoring of diseases, states, or conditions; medical testing to detect or identify predispositions to diseases, states, or conditions; medical testing to detect or determine the recurrence of diseases, states, or conditions; medical testing to detect, monitor, or evaluate responses to treatment of diseases, states, or conditions; medical testing to evaluate clinical management of diseases, states, or conditions; medical testing for selection of treatment for diseases, states, or conditions; medical testing to evaluate or facilitate prevention of diseases, states, or conditions; medical testing to select, facilitate, monitor, or evaluate palliation or treatment of diseases, states or conditions; medical testing in the field of cancer; medical testing in the field of oncology; medical diagnostic testing, monitoring, or reporting services; medical analysis or advisory services in the field of cancer; medical analysis or advisory services in the field of oncology; medical analysis or advisory services for medical treatment; medical analysis or advisory services for the diagnosis of diseases, states, or conditions; medical analysis or advisory services for the evaluation of prognosis relating to diseases, states, or conditions; medical analysis or advisory services relating to monitoring diseases, states, or conditions; medical analysis or advisory services relating to the detection or identification of predispositions to diseases, states, or conditions; medical analysis or advisory services relating to the detection or determination of the recurrence of diseases, states, or conditions; medical analysis or advisory services relating to the detection, monitoring, or evaluation of responses to treatment of diseases, states, or conditions; medical analysis or advisory services relating to the clinical management of diseases, states, or conditions; medical analysis or advisory services relating to the selection of treatment for diseases, states, or conditions; medical analysis or advisory services relating to the prevention of diseases, states, or conditions; medical analysis or advisory services relating to the palliation or treatment of diseases, states or conditions; qualitative image analysis in the field of digital pathology for medical purposes; quantitative image analysis in the field of digital pathology for medical purposes; providing non-research related medical information via the internet; medical analysis services for the diagnosis of cancer by reviewing pathological samples on slides
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2019-03-12
Primary Code
042
First Use Anywhere Date
2019-02-21
First Use In Commerce Date
2019-02-21
International Class
044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2019-03-12
Primary Code
044
First Use Anywhere Date
2019-02-21
First Use In Commerce Date
2019-02-21
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
03 - Corporation
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Mark Leonardo
Address
Please log in with your Justia account to see this address.
Madrid International Filings
Entry Number
1
Reference Number
A0101861
Original Filing Date USPTO
2020-11-03
International Registration Number
1583257
International Registration Date
2020-11-03
International Status Code
480
International Renewal Date
2030-11-03
| Madrid History Events | ||
| Date | Code | Description |
| 2020-11-05 | MCERT | MANUALLY CERTIFIED |
| 2020-11-05 | APPST | IR CERTIFIED AND SENT TO IB |
| 2020-11-03 | NEWAP | NEW APPLICATION FOR IR RECEIVED |
| 2021-03-30 | CBNAR | CEASING OF EFFECT REVIEWED - NO ACTION REQUIRED BY OFFICE |
| 2021-02-22 | IRRAC | RESPONSE TO IRREGULARITY REVIEWED AND ACCEPTED |
| 2021-02-22 | IRSNT | IRREGULARITY RESPONSE SENT TO IB |
| 2021-02-19 | IRRCV | IRREGULARITY RESPONSE RECEIVED FROM APPLICANT |
| 2021-03-26 | CREAT | APPLICATION FOR IR REGISTERED BY IB |
| 2021-03-26 | CBPCP | PARTIAL CEASING OF EFFECT TO BE PROCESSED |
| 2020-12-28 | IRREG | IRREGULARITY NOTICE RECEIVED FROM IB |
Trademark Events
| Event Date | Event Description |
| 2019-02-23 | NEW APPLICATION ENTERED IN TRAM |
| 2019-03-12 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2019-05-01 | ASSIGNED TO EXAMINER |
| 2019-05-15 | EXAMINERS AMENDMENT -WRITTEN |
| 2019-05-15 | EXAMINERS AMENDMENT E-MAILED |
| 2019-05-15 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 2019-05-15 | EXAMINER'S AMENDMENT ENTERED |
| 2019-05-15 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2019-05-29 | ASSIGNED TO LIE |
| 2019-06-12 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2019-07-02 | PUBLISHED FOR OPPOSITION |
| 2019-07-02 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2019-07-31 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| 2019-08-14 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2019-08-14 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2019-09-11 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
| 2019-10-22 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 2020-04-22 | TEAS EXTENSION RECEIVED |
| 2020-04-22 | EXTENSION 1 FILED |
| 2020-04-22 | EXTENSION 1 GRANTED |
| 2020-04-24 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 2020-07-08 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 2020-07-08 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2020-07-08 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2020-07-08 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 2020-07-08 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 2020-07-31 | TEAS STATEMENT OF USE RECEIVED |
| 2020-08-12 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 2020-07-31 | USE AMENDMENT FILED |
| 2020-08-13 | STATEMENT OF USE PROCESSING COMPLETE |
| 2020-09-11 | SU - NON-FINAL ACTION - WRITTEN |
| 2020-09-11 | NON-FINAL ACTION E-MAILED |
| 2020-09-11 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2020-10-13 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2020-10-13 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 2020-10-13 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2020-10-13 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2020-10-13 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 2020-10-13 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 2020-10-21 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2020-10-21 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2020-10-21 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 2020-10-22 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 2020-11-24 | REGISTERED-PRINCIPAL REGISTER |
| 2021-01-29 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 2021-01-29 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| 2021-01-29 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| 2021-01-29 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 2021-01-29 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
